Fetal malformations in an epileptic pregnant woman treated with carbamazepine

Zentralbl Gynakol. 1996;118(3):169-71.

Abstract

We report a case of an epileptic pregnant woman at 20 weeks of gestation treated with carbamazepine, whose fetus was affected by major malformations probably due to the drug teratogenicity. After a therapeutic abortion minor malformations were also found. After seven months the patient was pregnant again, at 14 weeks of gestation she aborted spontaneously a fetus with no malformations. During this pregnancy the patient took a reduced dosage of carbamazepine.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Drug-Induced / diagnostic imaging
  • Abnormalities, Drug-Induced / etiology*
  • Abortion, Eugenic
  • Adult
  • Anticonvulsants / administration & dosage
  • Anticonvulsants / adverse effects*
  • Carbamazepine / administration & dosage
  • Carbamazepine / adverse effects*
  • Epilepsy / diagnostic imaging
  • Epilepsy / drug therapy*
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications / diagnostic imaging
  • Pregnancy Complications / drug therapy*
  • Pregnancy Trimester, Second
  • Ultrasonography, Prenatal

Substances

  • Anticonvulsants
  • Carbamazepine